Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004560907 | SCV005047222 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2023-09-27 | criteria provided, single submitter | clinical testing | The p.I402T variant (also known as c.1205T>C), located in coding exon 11 of the LZTR1 gene, results from a T to C substitution at nucleotide position 1205. The isoleucine at codon 402 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |